Cargando…
Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent
Thymosin beta 4 (Tβ(4)) is a low molecular weight protein present in all cells except erythrocytes. Although Tβ(4) is the major monomeric actin-sequestering peptide in cells and can depolymerize F-actin, evidence is mounting to support the idea that it has multiple, seemingly diverse, cellular funct...
Autores principales: | Sosne, Gabriel, Qiu, Ping, Kurpakus-Wheater, Michelle |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701135/ https://www.ncbi.nlm.nih.gov/pubmed/19668473 |
Ejemplares similares
-
Adjunctive Thymosin Beta-4 Treatment Influences PMN Effector Cell Function during Pseudomonas aeruginosa-Induced Corneal Infection
por: Wang, Yuxin, et al.
Publicado: (2021) -
A novel dimeric thymosin beta 4 with enhanced activities accelerates the rate of wound healing
por: Xu, Tian-Jiao, et al.
Publicado: (2013) -
Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model
por: Sosne, Gabriel, et al.
Publicado: (2015) -
Antimicrobial Effects of Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy in Pseudomonas aeruginosa Induced Keratitis
por: Carion, Thomas W., et al.
Publicado: (2020) -
Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy Improves Pseudomonas aeruginosa-Induced Keratitis
por: Carion, Thomas W, et al.
Publicado: (2018)